T1	DISO 1 24	Endurecimiento arterial
#1	AnnotatorNotes T1	C0599949; Arterial Stiffness; Pathologic Function
T2	ANAT 16 24	arterial
#2	AnnotatorNotes T2	C0003842; Arteries; Body Part, Organ, or Organ Component | C1285085; Entire artery; Body Part, Organ, or Organ Component
T3	PROC 31 47	trasplante renal
#3	AnnotatorNotes T3	C0022671; Kidney Transplantation; Therapeutic or Preventive Procedure
T4	PROC 49 69	estudio caso-control
T5	CHEM 560 574	inmunosupresor
#4	AnnotatorNotes T5	C0021081; Immunosuppressive Agents; Immunologic Factor · Pharmacologic Substance
T6	PROC 115 141	tratamiento inmunosupresor
#5	AnnotatorNotes T6	C0021079; Therapeutic immunosuppression; Therapeutic or Preventive Procedure
T7	DISO 1904 1928	eventos cardiovasculares
#6	AnnotatorNotes T7	C1320716; Cardiovascular event; Finding
T8	CHEM 174 204	inhibidores de la calcineurina
#7	AnnotatorNotes T8	C1562036; Calcineurin inhibitor; Pharmacologic Substance
T9	ANAT 475 483	carótido
#8	AnnotatorNotes T9	C0007272; Carotid Arteries; Body Part, Organ, or Organ Component
T10	DISO 222 245	endurecimiento arterial
#9	AnnotatorNotes T10	C0599949; Arterial Stiffness; Pathologic Function
T11	PROC 432 491	medición de la velocidad de onda del pulso carótido-femoral
T12	ANAT 291 305	cardiovascular
#10	AnnotatorNotes T12	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T13	PROC 493 498	VOPcf
T14	PROC 358 369	trasplantes
#11	AnnotatorNotes T14	C0040732; Transplantation; Therapeutic or Preventive Procedure
T15	ANAT 373 380	renales
#12	AnnotatorNotes T15	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T16	ANAT 484 491	femoral
#13	AnnotatorNotes T16	C0015801; Structure of femoral artery; Body Part, Organ, or Organ Component | C1280173; Entire femoral artery; Body Part, Organ, or Organ Component
T17	CHEM 627 630	ICN
#14	AnnotatorNotes T17	C1562036; Calcineurin inhibitor; Pharmacologic Substance
T18	PROC 548 574	tratamiento inmunosupresor
#15	AnnotatorNotes T18	C0021079; Therapeutic immunosuppression; Therapeutic or Preventive Procedure
T19	PROC 649 654	VOPcf
T20	CHEM 595 625	inhibidores de la calcineurina
#16	AnnotatorNotes T20	C1562036; Calcineurin inhibitor; Pharmacologic Substance
T21	DISO 686 709	endurecimiento arterial
#17	AnnotatorNotes T21	C0599949; Arterial Stiffness; Pathologic Function
T22	PROC 738 749	tratamiento
#18	AnnotatorNotes T22	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T23	PROC 775 809	estudio retrospectivo caso-control
T24	CHEM 1054 1057	ICN
#19	AnnotatorNotes T24	C1562036; Calcineurin inhibitor; Pharmacologic Substance
T25	PROC 1245 1250	VOPcf
T26	PROC 865 908	tratamiento inmunosupresor de mantenimiento
T27	CHEM 913 923	belatacept
#20	AnnotatorNotes T27	C1619962; belatacept; Immunologic Factor · Amino Acid, Peptide, or Protein · Pharmacologic Substance
T28	CHEM 1382 1385	ICN
#21	AnnotatorNotes T28	C1562036; Calcineurin inhibitor; Pharmacologic Substance
T29	PROC 1038 1049	tratamiento
#22	AnnotatorNotes T29	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T30	DISO 1102 1125	endurecimiento arterial
#23	AnnotatorNotes T30	C0599949; Arterial Stiffness; Pathologic Function
T31	PROC 1136 1147	seguimiento
#24	AnnotatorNotes T31	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T32	PROC 1197 1207	trasplante
#25	AnnotatorNotes T32	C0040732; Transplantation; Therapeutic or Preventive Procedure
T33	PROC 1486 1491	VOPcf
T34	CHEM 1324 1334	belatacept
#26	AnnotatorNotes T34	C1619962; belatacept; Immunologic Factor · Amino Acid, Peptide, or Protein · Pharmacologic Substance
T35	CHEM 1352 1355	BLC
#27	AnnotatorNotes T35	C1619962; belatacept; Immunologic Factor · Amino Acid, Peptide, or Protein · Pharmacologic Substance
T36	PROC 1711 1716	VOPcf
T37	ANAT 1586 1591	renal
#28	AnnotatorNotes T37	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T38	PROC 1618 1629	tratamiento
#29	AnnotatorNotes T38	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T39	PROC 1745 1777	inmunosupresión de mantenimiento
T40	CHEM 1782 1792	belatacept
#30	AnnotatorNotes T40	C1619962; belatacept; Immunologic Factor · Amino Acid, Peptide, or Protein · Pharmacologic Substance
T41	ANAT 1912 1928	cardiovasculares
#31	AnnotatorNotes T41	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T42	DISO 1949 1972	endurecimiento arterial
#32	AnnotatorNotes T42	C0599949; Arterial Stiffness; Pathologic Function
T43	CHEM 754 757	ICN
#33	AnnotatorNotes T43	C1562036; Calcineurin inhibitor; Pharmacologic Substance
T44	ANAT 42 47	renal
#34	AnnotatorNotes T44	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T45	ANAT 1864 1871	renales
#35	AnnotatorNotes T45	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T46	CHEM 146 156	belatacept
#36	AnnotatorNotes T46	C1619962; belatacept; Immunologic Factor · Amino Acid, Peptide, or Protein · Pharmacologic Substance
T47	ANAT 237 245	arterial
#37	AnnotatorNotes T47	C0003842; Arteries; Body Part, Organ, or Organ Component | C1285085; Entire artery; Body Part, Organ, or Organ Component
T48	CHEM 579 589	belatacept
#38	AnnotatorNotes T48	C1619962; belatacept; Immunologic Factor · Amino Acid, Peptide, or Protein · Pharmacologic Substance
T49	ANAT 701 709	arterial
#39	AnnotatorNotes T49	C0003842; Arteries; Body Part, Organ, or Organ Component | C1285085; Entire artery; Body Part, Organ, or Organ Component
T50	ANAT 1117 1125	arterial
#40	AnnotatorNotes T50	C0003842; Arteries; Body Part, Organ, or Organ Component | C1285085; Entire artery; Body Part, Organ, or Organ Component
T51	CHEM 1634 1644	belatacept
#41	AnnotatorNotes T51	C1619962; belatacept; Immunologic Factor · Amino Acid, Peptide, or Protein · Pharmacologic Substance
T52	PROC 1852 1871	trasplantes renales
#42	AnnotatorNotes T52	C0022671; Kidney Transplantation; Therapeutic or Preventive Procedure
T53	ANAT 1964 1972	arterial
#43	AnnotatorNotes T53	C0003842; Arteries; Body Part, Organ, or Organ Component | C1285085; Entire artery; Body Part, Organ, or Organ Component
T54	Date 206 217	Actualmente
T55	PHYS 469 491	pulso carótido-femoral
#44	AnnotatorNotes T55	C1096529; Carotid pulse; Organ or Tissue Function + C0232148; Femoral pulse; Organ or Tissue Function
T56	Neg_cue 591 594	sin
T57	LIVB 980 998	grupo de controles
T58	Duration 1171 1181	los 5 años
T59	LIVB 1227 1236	pacientes
#45	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T64	LIVB 318 335	población general
#46	AnnotatorNotes T64	C0683971; General Population; Population Group
T66	CHEM 877 891	inmunosupresor
#47	AnnotatorNotes T66	C0021081; Immunosuppressive Agents; Immunologic Factor · Pharmacologic Substance
T60	DISO 280 305	mortalidad cardiovascular
T61	LIVB 62 69	control
#48	AnnotatorNotes T61	C0009932; Control Groups; Group
T62	LIVB 57 61	caso
#49	AnnotatorNotes T62	C2348561; Study group; Group
T63	LIVB 344 354	receptores
#50	AnnotatorNotes T63	C0376387; Transplant Recipients; Patient or Disabled Group
A1	Assertion T20 Negated
A2	Assertion T17 Negated
R1	Location_of Arg1:T2 Arg2:T1	
R2	Location_of Arg1:T44 Arg2:T3	
R3	Used_for Arg1:T46 Arg2:T6	
R4	Used_for Arg1:T8 Arg2:T6	
R5	Location_of Arg1:T47 Arg2:T10	
R6	Experiences Arg1:T64 Arg2:T60	
R7	Experiences Arg1:T64 Arg2:T10	
R8	Experiences Arg1:T63 Arg2:T60	
R9	Experiences Arg1:T63 Arg2:T10	
R10	Experiences Arg1:T63 Arg2:T14	
R11	Location_of Arg1:T15 Arg2:T14	
R12	Location_of Arg1:T9 Arg2:T55	
R13	Location_of Arg1:T16 Arg2:T55	
R14	Location_of Arg1:T9 Arg2:T11	
R15	Location_of Arg1:T16 Arg2:T11	
R16	Location_of Arg1:T16 Arg2:T13	
R17	Location_of Arg1:T9 Arg2:T13	
R18	Used_for Arg1:T48 Arg2:T18	
R19	Used_for Arg1:T5 Arg2:T18	
R20	Negation Arg1:T56 Arg2:T20	
R21	Negation Arg1:T56 Arg2:T17	
R22	Location_of Arg1:T49 Arg2:T21	
R23	Used_for Arg1:T43 Arg2:T22	
T65	LIVB 797 801	caso
#51	AnnotatorNotes T65	C2348561; Study group; Group
T67	LIVB 802 809	control
#52	AnnotatorNotes T67	C0009932; Control Groups; Group
R24	Used_for Arg1:T66 Arg2:T26	
R25	Used_for Arg1:T27 Arg2:T26	
#53	AnnotatorNotes T57	C0009932; Control Groups; Group
R26	Used_for Arg1:T24 Arg2:T29	
R27	Experiences Arg1:T57 Arg2:T29	
R28	Experiences Arg1:T57 Arg2:T30	
R29	Location_of Arg1:T50 Arg2:T30	
R30	Has_Duration_or_Interval Arg1:T31 Arg2:T58	
R31	After Arg1:T31 Arg2:T32	
R32	Experiences Arg1:T59 Arg2:T25	
R33	Experiences Arg1:T59 Arg2:T32	
R34	Experiences Arg1:T59 Arg2:T34	
R35	Experiences Arg1:T59 Arg2:T35	
R36	Experiences Arg1:T59 Arg2:T28	
R37	Before Arg1:T32 Arg2:T34	
R38	Before Arg1:T32 Arg2:T35	
R39	Before Arg1:T32 Arg2:T28	
T68	CONC 1402 1447	análisis de regresión logística multivariante
T69	Result_or_Value 1492 1496	alta
R40	Has_Result_or_Value Arg1:T33 Arg2:T69	
T70	CONC 1564 1591	índice de resistencia renal
R41	Used_for Arg1:T51 Arg2:T38	
R42	Used_for Arg1:T40 Arg2:T39	
T71	LIVB 1838 1848	receptores
#54	AnnotatorNotes T71	C0376387; Transplant Recipients; Patient or Disabled Group
R43	Location_of Arg1:T45 Arg2:T52	
R44	Experiences Arg1:T71 Arg2:T52	
R45	Location_of Arg1:T41 Arg2:T7	
R46	Location_of Arg1:T53 Arg2:T42	
R47	Overlap Arg1:T7 Arg2:T42	
R48	Experiences Arg1:T71 Arg2:T7	
R49	Experiences Arg1:T71 Arg2:T42	
R50	Experiences Arg1:T71 Arg2:T39	
R52	Before Arg1:T10 Arg2:T60	
R55	Experiences Arg1:T65 Arg2:T26	
T72	LIVB 841 846	casos
#55	AnnotatorNotes T72	C2348561; Study group; Group
R56	Experiences Arg1:T72 Arg2:T26	
T73	CONC 1813 1834	tasa de supervivencia
#56	AnnotatorNotes T73	C0038954; Survival Rate; Quantitative Concept
R59	Experiences Arg1:T62 Arg2:T3	
R60	Experiences Arg1:T62 Arg2:T1	
R61	Experiences Arg1:T61 Arg2:T3	
R62	Experiences Arg1:T61 Arg2:T1	
R63	Experiences Arg1:T62 Arg2:T6	
R64	Experiences Arg1:T61 Arg2:T6	
T74	Spec_cue 1793 1799	podría
T75	CONC 1800 1809	favorecer
A3	Assertion T75 Speculated
#57	AnnotatorNotes T68	C0206031; Logistic Regression; Research Activity + C0026777; Multivariate Analysis; Quantitative Concept
T76	CONC 1511 1525	correlacionado
#58	AnnotatorNotes T76	C1707520; Correltion; Qualitative Concept
#59	AnnotatorNotes T69	C0205250; High; Qualitative Concept
R51	Speculation Arg1:T74 Arg2:T75	
T77	Spec_cue 542 544	si
T78	CONC 633 642	se asocia
A4	Assertion T78 Speculated
#60	AnnotatorNotes T78	C0332281; Associated with; Qualitative Concept
R57	Speculation Arg1:T77 Arg2:T78	
#61	AnnotatorNotes T54	C0521116; Current (present time); Temporal Concept
T79	CONC 447 491	velocidad de onda del pulso carótido-femoral
#62	AnnotatorNotes T79	C5197774; Carotid-Femoral Pulse Wave Velocity; Quantitative Concept
A5	Experiencer T63 Patient
A6	Experiencer T64 Patient
A7	Experiencer T65 Patient
A8	Experiencer T67 Patient
A9	Experiencer T72 Patient
A10	Experiencer T57 Patient
A11	Experiencer T59 Patient
A12	Experiencer T71 Patient
A13	Experiencer T62 Patient
A14	Experiencer T61 Patient
